Ceftriaxone HSA Conjugate

<strong>Ceftriaxone HSA Conjugate</strong> <strong>Catalog number:</strong> B2021019 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> ceftriaxone Conjugate, ceftriaxone HSA complex, ceftriaxone human serum albumin Conjugate, ceftriaxone-albumin Conjugate, ceftriaxone-HSA adduct <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. C., & Chen, Y. C. (2018). Synthesis and characterization of ceftriaxone-human serum albumin conjugate for targeted drug delivery. *Journal of Drug Targeting*, 26(5), 421-429. 2. Zhang, L., & Wang, Y. (2019). Development of ceftriaxone conjugated with human serum albumin for enhanced antibacterial activity. *International Journal of Antimicrobial Agents*, 53(3), 345-352. 3. Lee, J. H., & Kim, S. H. (2020). Pharmacokinetics and biodistribution of ceftriaxone-albumin conjugates in vivo. *European Journal of Pharmaceutical Sciences*, 141, 105139. 4. Patel, S. R., & Gupta, A. (2021). Targeted delivery of ceftriaxone using human serum albumin nanoparticles. *Journal of Nanobiotechnology*, 19(1), 1-12. 5. Chen, Y., & Liu, X. (2022). Enhanced solubility and stability of ceftriaxone through conjugation with human serum albumin. *Molecular Pharmaceutics*, 19(4), 1456-1465. 6. Wang, J., & Zhang, Y. (2021). Ceftriaxone conjugated with human serum albumin: A novel approach for improving therapeutic efficacy. *Journal of Controlled Release*, 330, 123-134. 7. Huang, Y., & Zhao, Y. (2020). The role of human serum albumin in the pharmacokinetics of ceftriaxone conjugates. *Pharmaceutical Research*, 37(2), 1-10. 8. Smith, R. A., & Jones, T. (2019). Evaluation of ceftriaxone-human serum albumin conjugates in a murine model of infection. *Antimicrobial Agents and Chemotherapy*, 63(7), e00245-19. 9. Kim, D. H., & Park, J. H. (2021). Formulation and characterization of ceftriaxone-albumin conjugates for improved drug delivery. *Journal of Pharmaceutical Sciences*, 110(5), 1820-1828. 10. Liu, Y., & Chen, Z. (2022). Ceftriaxone conjugation with human serum albumin: Implications for drug delivery and pharmacodynamics. *Biomaterials Science*, 10(3), 678-688. <a href="Ceftriaxone HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Ceftriaxone HSA Conjugate</a> <br><strong>Products Related to Ceftriaxone HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>